XML 21 R9.htm IDEA: XBRL DOCUMENT
v3.20.2

CASH EQUIVALENTS AND MARKETABLE SECURITIES | 9 Months Ended
--- | ---
Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract] |
CASH EQUIVALENTS AND MARKETABLE SECURITIES | CASH EQUIVALENTS AND MARKETABLE SECURITIES Cash Equivalents and Marketable Securities The table below summarizes the Company’s cash equivalents and marketable securities (in thousands):
|  | Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized (Losses) |  | Estimated Fair Value
September 30, 2020 |  |  |  |  |  |  |  |
Assets |  |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |  |
Money market funds |  | $ | 172,508 |  |  | $ | — |  |  | $ | — |  |  | $ | 172,508 |
Commercial paper securities |  | 5,998 |  |  | 1 |  |  | — |  |  | 5,999 |
Total |  | 178,506 |  |  | 1 |  |  | — |  |  | 178,507 |
Marketable securities: |  |  |  |  |  |  |  |
Commercial paper securities |  | 238,248 |  |  | 169 |  |  | (19) |  |  | 238,398 |
Corporate debt securities |  | 122,364 |  |  | 156 |  |  | (36) |  |  | 122,484 |
Asset-backed securities |  | 13,067 |  |  | 3 |  |  | (4) |  |  | 13,066 |
U.S. government-sponsored entity debt securities |  | 61,171 |  |  | 76 |  |  | — |  |  | 61,247 |
Total |  | 434,850 |  |  | 404 |  |  | (59) |  |  | 435,195 |
Total cash equivalents and marketable securities |  | $ | 613,356 |  |  | $ | 405 |  |  | $ | (59) |  |  | $ | 613,702 |
December 31, 2019 |  |  |  |  |  |  |  |
Assets |  |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |  |
Money market funds |  | $ | 30,496 |  |  | $ | — |  |  | $ | — |  |  | $ | 30,496 |
Commercial paper securities |  | 2,998 |  |  | 1 |  |  | — |  |  | 2,999 |
Total |  | 33,494 |  |  | 1 |  |  | — |  |  | 33,495 |
Marketable securities: |  |  |  |  |  |  |  |
Commercial paper securities |  | 155,230 |  |  | 145 |  |  | (7) |  |  | 155,368 |
Corporate debt securities |  | 94,905 |  |  | 115 |  |  | (3) |  |  | 95,017 |
U.S. government-sponsored entity debt securities |  | 53,411 |  |  | 91 |  |  | (9) |  |  | 53,493 |
Total |  | 303,546 |  |  | 351 |  |  | (19) |  |  | 303,878 |
Total cash equivalents and marketable securities |  | $ | 337,040 |  |  | $ | 352 |  |  | $ | (19) |  |  | $ | 337,373 |
The fair value of investments available-for-sale by contractual maturity were as follows (in thousands):
|  | September 30, 2020 |  | December 31, 2019
Maturing in one year or less |  | $ | 389,434 |  |  | $ | 282,046 |
Maturing after one year through five years |  | 45,761 |  |  | 21,832 |
Total |  | $ | 435,195 |  |  | $ | 303,878 |
The Company had no realized losses of its available-for-sale securities for the three and nine months ended September 30, 2020 or 2019. The Company periodically reviews the available-for-sale investments for other-than-temporary impairment losses. No investments were other-than-temporarily impaired at either September 30, 2020 or December 31, 2019. The Company considers factors such as the duration, severity and the reason for the decline in value, the potential recovery period, creditworthiness of the issuers of the securities and its intent to sell. For available-for-sale securities, it also considers whether (i) it is more likely than not that the Company will be required to sell the debt securities before recovery of their amortized cost basis, and (ii) the amortized cost basis cannot be recovered as a result of credit losses. No significant facts or circumstances have arisen to indicate that there has been any significant deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company's review of these securities, including the assessment of the duration and severity of the unrealized losses and the Company's ability and intent to hold the investments until maturity, there were no other-than-temporary impairments for these securities at September 30, 2020.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2209399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2324412 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2176304 + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration